.
Pharmacology
Study Course Description
Course Description Statuss:Approved
Course Description Version:1.00
Study Course Accepted:18.08.2020 12:14:12
| Study Course Information | |||||||||
| Course Code: | LF_435 | LQF level: | Level 6 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Clinical Medicine | Target Audience: | Nursing Science | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Inga Petermane | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | RSU Liepāja Branch | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | |||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 5 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 10 | ||||
| Classes (count) | 11 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 22 | ||||
| Total Contact Hours | 32 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Anatomy, physiology, biochemistry and histology, pathology. | ||||||||
| Objective: | Students should acquire knowledge of the pharmacological groups and preparations of the medicinal product, assess the efficacy and safety of the medicinal product, know what information should be provided on the medicinal product for the patient's safe use. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | General pharmacology. Introduction to the recipe | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| 2 | Pharmacology of the afferented system | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| 3 | Pharmacology of the eferenated system I | Classes | 1.00 | auditorium | |||||
| 4 | Pharmacology of the eferenated system II | Classes | 1.00 | auditorium | |||||
| 5 | Pharmacology of the central nervous system I | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| 6 | Pharmacology of the central nervous system II | Classes | 1.00 | auditorium | |||||
| 7 | Colloquium | Classes | 1.00 | auditorium | |||||
| 8 | Medicinal products affecting metabolism | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| 9 | Anti-inflammatory and immunity-affecting agents | Classes | 1.00 | auditorium | |||||
| 10 | Antimicrobial and anti-parasitic agents | Lectures | 1.00 | auditorium | |||||
| Classes | 1.00 | auditorium | |||||||
| 11 | Test | Classes | 1.00 | auditorium | |||||
| Assessment | |||||||||
| Unaided Work: | Individual work – the acquisition of general and clinical pharmacology, as well as the selection and analysis of information on medicinal products, their use and use in the medical process. | ||||||||
| Assessment Criteria: | Regular short tests during practice. Final test – exam. | ||||||||
| Final Examination (Full-Time): | Exam (Written) | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | As a result of learning the course, students acquire basic knowledge and competence in the pharmacodynamics and pharmacokinetics of medicinal products, will know the drug groups and the use of medicinal products for the prevention and treatment of diseases. Students will be able to formulate mechanisms, indications and side effects for drug substances. | ||||||||
| Skills: | As a result of studying the course, students will be able to make choice of medicines, based on their effectiveness and safety assessment, and will acquire skills in obtaining information on medicines. | ||||||||
| Competencies: | As a result of studying the course, students will be able to provide information to the patient about the medicine. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Indulis Purviņš, Santa Purviņa. Praktiskā farmakoloģija. 4. Izdevums, ZIC, 2011 | ||||||||
| 2 | Basic & Clinical Pharmacology. Bertram G. Katzung. McGraw-Hill Professional, 2006, 1179 lpp. | ||||||||
| 3 | Lekciju materiāls RSU E-studijas | ||||||||
| Additional Reading | |||||||||
| 1 | Clinical Pharmacy and Therapeutics. Roger Walker, Clive Edwards. Churchill Livingstone, 2003, 937 lpp. | ||||||||
| 2 | Introductory Clinical Pharmacology. Sally S. Roach, Susan M. Ford. Lippincott Williams & Wilkins, 2008, 800 lpp. | ||||||||
| 3 | Biksone G. Medikamentozā ārstēšana un aprūpe. Rīga: Kerena, 2002 | ||||||||
| 4 | Pharmacotherapy Handbook. Barbara G Wells. McGraw-Hill Professional, 2006 | ||||||||
| 5 | Goodman and Gilman’s. The Pharmacological Basis of Therapeutics. Louis Sanford Goodman, Laurence L. Brunton, Alfred Gilman, John S. Lazo, Alfred Goodman Gilman, Keith L. Parker. McGraw-Hill, 2011 | ||||||||
| 6 | Goodman & Gilman's: The Pharmacological Basis of Therapeutics, Thirteenth Edition ISBN 978-1-25-958473-2 | ||||||||
| Other Information Sources | |||||||||
| 1 | www.vm.gov.lv | ||||||||
| 2 | www.EMCDDA.europa.eu/ | ||||||||
| 3 | www.euphix.org/ | ||||||||
| 4 | http://ec.europa.eu/health-eu/ | ||||||||
| 5 | http://www. haiweb.org/ | ||||||||
| 6 | Latvijas Zāļu valsts aģentūras Zāļu patēriņa statistika | ||||||||
